Tuesday, June 26, 2018

Marijuana going mainstream as FDA approves first ever cannabis based medicine

In an interesting and perhaps even groundbreaking sea-change, the FDA on June 25 approved the first ever cannabis based prescription medicine meant to aid on the treatment of rare forms of epilepsy and two other diseases.

The Food and Drug Administration has approved the first-ever cannabis-based prescription medication. The oral drug Epidiolex is intended for patients to treat two rare, and severe forms of epilepsy—Lennox-Gastaut syndrome and Dravet syndrome.

Epidiolex contains cannabidiol, one of the chemicals found in marijuana, however, it will not produce a high that is commonly seen in THC. FDA commissioner Dr. Scott Gottlieb stressed in a statement that approval of the drug wasn’t a co-sign for marijuana, but just for "one specific CBD medication for a specific use." It also marks a landmark moment in the agency’s advancement in considering cannabis for medical purposes.  
"This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And, the FDA is committed to this kind of careful scientific research and drug development," Dr. Gottlieb said. "Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients." - Complex
Hopefully this approval now opens the door for more research and acceptance of cannabis to one day replace opioid based drugs for pain relief that have spawned a severe and very real epidemic among America's patients.

0 comments:

Post a Comment